{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:50:36Z","timestamp":1744699836123,"version":"3.38.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Tay-Sachs & Allied Diseases Association Inc."},{"name":"Sanofi US Services Inc."},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GLIA-CTN U54TR002823","R00EB016689"],"award-info":[{"award-number":["GLIA-CTN U54TR002823","R00EB016689"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Functional Neuroimaging Technologies","award":["P41EB015896"],"award-info":[{"award-number":["P41EB015896"]}]},{"name":"Center for Mesoscale Mapping","award":["P41EB030006"],"award-info":[{"award-number":["P41EB030006"]}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-025-01803-4","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:14:52Z","timestamp":1739902492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brainstem Substructure Atrophy in Late-Onset GM2-Gangliosidosis Imaging Using Automated Segmentation"],"prefix":"10.1007","volume":"24","author":[{"given":"Olivia E.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rangaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian S.","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D.","family":"Schmahmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"1803_CR1","doi-asserted-by":"publisher","first-page":"136195","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro C, Zainab M, Tifft CJ. The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. Neurosci Lett. 2021;764:136195. https:\/\/doi.org\/10.1016\/j.neulet.2021.136195.","journal-title":"Neurosci Lett."},{"issue":"1","key":"1803_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/acn3.51947","volume":"11","author":"NP Godbole","year":"2024","unstructured":"Godbole NP, Haxton E, Rowe OE, et al. Clinical and imaging predictors of late-onset GM2 gangliosidosis: A scoping review. Ann Clin Transl Neurol. 2024;11(1):207\u201324. https:\/\/doi.org\/10.1002\/acn3.51947.","journal-title":"Ann Clin Transl Neurol."},{"issue":"4","key":"1803_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ymgme.2021.06.008","volume":"133","author":"OE Rowe","year":"2021","unstructured":"Rowe OE, Rangaprakash D, Weerasekera A, et al. Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis. Mol Genet Metab. 2021;133(4):386\u201396. https:\/\/doi.org\/10.1016\/j.ymgme.2021.06.008.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"1803_CR4","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1212\/wnl.0000000000008959","volume":"94","author":"CD Stephen","year":"2020","unstructured":"Stephen CD, Balkwill D, James P, et al. Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis. Neurology. 2020;94(7):e705\u201317. https:\/\/doi.org\/10.1212\/wnl.0000000000008959.","journal-title":"Neurology"},{"issue":"5","key":"1803_CR5","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s10072-021-05757-3","volume":"43","author":"J M\u00e1jovsk\u00e1","year":"2022","unstructured":"M\u00e1jovsk\u00e1 J, Hennig A, Nestrasil I, et al. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease. Neurol Sci. 2022;43(5):3273\u201381. https:\/\/doi.org\/10.1007\/s10072-021-05757-3.","journal-title":"Neurol Sci"},{"issue":"3","key":"1803_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0896-6273(02)00569-x","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341\u201355. https:\/\/doi.org\/10.1016\/s0896-6273(02)00569-x.","journal-title":"Neuron"},{"key":"1803_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.02.065","volume":"113","author":"JE Iglesias","year":"2015","unstructured":"Iglesias JE, Van Leemput K, Bhatt P, et al. Bayesian segmentation of brainstem structures in MRI. Neuroimage. 2015;113:184\u201395. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.02.065.","journal-title":"Neuroimage"},{"issue":"3","key":"1803_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/neup.12088","volume":"34","author":"T Yokoyama","year":"2014","unstructured":"Yokoyama T, Nakamura S, Horiuchi E, et al. Late onset GM2 gangliosidosis presenting with motor neuron disease: an autopsy case. Neuropathology. 2014;34(3):304\u20138. https:\/\/doi.org\/10.1111\/neup.12088.","journal-title":"Neuropathology"},{"issue":"5","key":"1803_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5414\/npp27302","volume":"27","author":"M Kornfeld","year":"2008","unstructured":"Kornfeld M. Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase a deficiency. Clin Neuropathol. 2008;27(5):302\u20138. https:\/\/doi.org\/10.5414\/npp27302.","journal-title":"Clin Neuropathol"},{"issue":"4\u20135","key":"1803_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000112161","volume":"13","author":"K Suzuki","year":"1991","unstructured":"Suzuki K. Neuropathology of Late Onset Gangliosidoses: A review. Dev Neurosci. 1991;13(4\u20135):205\u201310. https:\/\/doi.org\/10.1159\/000112161.","journal-title":"Dev Neurosci"},{"issue":"1","key":"1803_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1152\/jn.00626.2002","volume":"89","author":"RP Dum","year":"2003","unstructured":"Dum RP, Strick PL. An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J Neurophysiol. 2003;89(1):634\u20139. https:\/\/doi.org\/10.1152\/jn.00626.2002.","journal-title":"J Neurophysiol"},{"key":"1803_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-neuro-070918-050258","volume":"42","author":"JD Schmahmann","year":"2019","unstructured":"Schmahmann JD, Guell X, Stoodley CJ, Halko MA. The theory and neuroscience of cerebellar cognition. Annu Rev Neurosci. 2019;42:337\u201364. https:\/\/doi.org\/10.1146\/annurev-neuro-070918-050258.","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"1803_CR13","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/cercor\/bhz247","volume":"30","author":"X Guell","year":"2020","unstructured":"Guell X, D\u2019Mello AM, Hubbard NA, et al. Functional territories of human dentate nucleus. Cereb Cortex. 2020;30(4):2401\u201317. https:\/\/doi.org\/10.1093\/cercor\/bhz247.","journal-title":"Cereb Cortex"},{"issue":"2","key":"1803_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.26824","volume":"95","author":"J Faber","year":"2024","unstructured":"Faber J, Berger M, Wilke C, et al. Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Ann Neurol. 2024;95(2):400\u20136. https:\/\/doi.org\/10.1002\/ana.26824.","journal-title":"Ann Neurol"},{"issue":"1","key":"1803_CR15","doi-asserted-by":"publisher","first-page":"fcae019","DOI":"10.1093\/braincomms\/fcae019","volume":"6","author":"CD Stephen","year":"2024","unstructured":"Stephen CD, Vangel M, Gupta AS, MacMore JP, Schmahmann JD. Rates of change of pons and middle cerebellar peduncle diameters are diagnostic of multiple system atrophy of the cerebellar type. Brain Commun. 2024;6(1):fcae019. https:\/\/doi.org\/10.1093\/braincomms\/fcae019.","journal-title":"Brain Commun."}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-025-01803-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:36:58Z","timestamp":1741700218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-025-01803-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1007\/s12311-025-01803-4","relation":{},"ISSN":["1473-4230"],"issn-type":[{"type":"electronic","value":"1473-4230"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"11 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mass General Brigham Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants underwent the informed consent process in accordance with the Ethical Principles and Guidelines for the Protection of Human Subjects of Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent to publish a participant\u2019s data was included within the informed consent documents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"O.E. Rowe was employed by Cognito Therapeutics at the time of analysis and drafting of the report.F.S. Eichler receives consulting fees from Ionis Pharmaceuticals and SwanBio Therapeutics and grant support from National Tay-Sachs and Allied Diseases and Cystinosis Research Foundation and has received financial support from bluebird bio and Minoryx Therapeutics for the conduct of clinical trials.J.D. Schmahmann is site PI for Biohaven Pharmaceuticals clinical trials NCT03701399 and NCT02960893; consults for Biohaven Pharmaceuticals; receives royalties from Oxford University Press, Elsevier, MacKeith Press, and Springer; and is the inventor of the Brief Ataxia Rating Scale, Cerebellar Cognitive Affective \/ Schmahmann Syndrome Scale, the Patient Reported Outcome Measure of Ataxia, and the Cerebellar Neuropsychiatry Rating Scale, which are licensed to the General Hospital Corporation. He is supported in part by the MINDlink foundation, the National Ataxia Foundation and the Raynor Cerebellum Project.R.L. Barry has been employed by the National Institute of Biomedical Imaging and Bioengineering at the NIH, USA since January 2024. This article was co-authored by R.L. Barry in his personal capacity. The opinions expressed in the article are his own and do not necessarily reflect the views of the NIH, the Department of Health and Human Services, or the United States government.C.D. Stephen has provided scientific advisory for SwanBio Therapeutics and received research funding from Sanofi-Genzyme for a study of video oculography in late-onset GM2 Gangliosidosis. His institution has received financial support from Sanofi-Genzyme, SwanBio Therapeutics and Encora Therapeutics and previously from Biogen and Biohaven, for the conduct of clinical trials. He has received honoraria from the American Academy of Neurology and The International Parkinson and Movement Disorders Society. He has received grant support from the National Institutes of Health K23 NS118045.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"50"}}